ACE and Hypertension: This meta‐analysis [32] extends the findings of previous landmark trials, such as the PROGRESS [30] and HOPE [31] trials, which showed the beneficial effects of antihypertensive treatment with ACE‐inhibitors in patients with or at high risk for CVD, even in the absence of hypertension.